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WHAT THIS PAPER ADDS
 This expanded series is a more accurate reﬂection of expected results conﬁrming that the distal vein patch bypass leads to
reasonable long-term results for those challenging patients that require prosthetic distal bypass for lower extremity revasculari-
zation. Vascular surgeons engaged in the treatment of patients with limb threatening ischemia may wish to add this technique to
their options for lower extremity revascularization for limb salvage.a r t i c l e i n f o
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Objectives: The endovascular ﬁrst approach has led to increasing complexity for surgical bypass especially
in those patients without autogenous conduit. The use of vein interposed at the distal anastomosis has
been reported to improve the results of prosthetic grafts. This series expands our initial experience with
the distal vein patch technique (DVP) reporting a larger cohort with enhanced follow-up.
Design: A retrospective review of prospectively collected data was performed for distal bypasses from
July 1995 to November 2008.
Materials/Methods: 1296 tibial bypasses were performed with 270 using the DVP technique. Patient
demographics included; 49% diabetes, 20% chronic renal failure, 33% prior failed bypass. Indications for
revascularization were claudication (9.3%), rest pain (27.8%), gangrene (22.2%), and non-healing ulcera-
tion (40.7%). Lack of vein for the bypass conduit resulted from previous failed grafts (55%), coronary
bypass (18%), poor quality vein (23%), or prior vein stripping (8%). Follow-up ranged from 1 to 48 months
with graft surveillance by pulse exam, ABI, and Duplex ultrasound. Primary patency and limb
salvage  SE were determined by KaplaneMeier life-table analysis using Rutherford criteria.
Results: Bypasses originated from the external iliac (29%), CFA (55%), SFA (13%), popliteal (1%), and prior
grafts (2%). Recipient arteries were below knee popliteal (6%), anterior tibial (25%), posterior tibial (30%),
and peroneal (39%). Perioperative graft failure occurred in 13 cases with a total of 41 graft failures leading
to 39 major amputations. Primary graft patency from one to four years was 79.8%, 75.6% 65.9%, and 51.2%.
Corresponding limb salvage rates were 80.6%, 78.0%, 75.7%, and 67.5%.
Conclusion: Although not addressed by a randomized trial, we believe this expanded series is a more
accurate reﬂection of expected results conﬁrming that the DVP bypass leads to reasonable long-term results
for those challenging patients that require prosthetic distal bypass for lower extremity revascularization.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Despite the rapid development of endovascular therapy, bypass
continues to play an important role in below knee revascularizationrgery, 36th Annual Scientiﬁc
).
ciety for Vascular Surgery. Publishefor limb threatening ischemia. An “endovascular ﬁrst” approach has
been adopted by many centers resulting in a decrease in the
number of lower extremity bypasses performed from critical limb
ischemia.1 The only randomized trial to compare angioplasty and
bypass is the BASIL trial (Bypass versus Angioplasty in Severe
Ischemia of the Leg).2 This comparison suggested that bypass may
be the preferred method of revascularization in patients with more
than a two year life expectancy and the presence of good qualityd by Elsevier Ltd. All rights reserved.
Figure 1. Intraoperative view of the DVP anastomosis with prosthetic, vein patch and
artery. A. ePTFE being sutured to the venotomy in the vein patch. B. Completed
anastomosis.
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provide the best patency and remains the preferred conduit,
adequate autogenous tissue may not be available leaving a pros-
thetic graft an option for certain patients.3,4 This group has been
estimated at 30% of those needing distal reconstruction with an
increase to 50% for those undergoing a repeat or secondary
procedure.5 Unfortunately, reported patency for below knee bypass
with a prosthetic graft ranges between 20% and 50% at one year and
12%e40% at three years.3,6e8
Attempts to improve the performance of prosthetic grafts have
included the interposition of venous tissue at the distal anasto-
mosis in the form of cuffs, collars, and boots. The distal vein patch
technique was initially developed to enhance the performance of
polytetraﬂuoroethylene (PTFE) bypasses while taking advantage of
anastomotic techniques familiar to vascular surgeons.9 Our initial
experiencewith this techniquewas reported in 2001 for a relatively
small patient cohort with limited follow-up.10 The current series
examines the results of a larger and more mature patient pop-
ulation requiring below knee bypass using PTFE with a distal vein
patch (DVP).
Materials and Methods
A retrospective review of prospectively collected data was per-
formed (with IRB approval, No. 2008-091) for all below knee
bypasses using the distal vein patch (DVP) technique from July 1995
to November 2008. During the review period, 270 infrapopliteal
prosthetic bypass grafts were performed in 252 patients using the
DVP technique. During this time period there were a total of 1296
infrapopliteal bypasses performed so that the DVP group repre-
sented 20.8% of the below knee bypass experience. All prosthetic
grafts used were expanded polytetraﬂuoroethylene (PTFE) with
external, removable rings (WL GoreR, Flagstaff, AZ). Arteriography
was performed in all patients for preoperative planning of the
bypass. Prior to the decision to use PTFE with a DVP, efforts were
expended to ﬁnd autogenous venous tissue suitable to use as
a bypass conduit. Physical examination supplemented with Duplex
ultrasonographywas conducted to locate ipsilateral or contralateral
saphenous vein. If vein of adequate length but questionable quality
was identiﬁed, then evaluation under direct vision was performed
intraoperatively with gentle hydrostatic dilation. The use of pros-
thetic graft material occurred due to a lack of autogenous vein for
the following reasons; coronary artery bypass (18%), prior lower
extremity bypass (55%), venous stripping (8%), or poor vein quality
of insufﬁcient length or diameter (23%).
Bypass procedures were performed under general or epidural
anesthesia based on the patient’s medical condition and the judg-
ment of the attending anesthesiologist. A retroperitoneal approach
to the external iliac artery was used in several cases to avoid groin
scarring due to previous femoral artery dissection from prior bypass
procedures. This incision was made several centimeters above and
parallel to the inguinal ligament with dissection through the
external oblique fascia and transection of the internal oblique and
transversalis muscle ﬁbers to enter the retroperitoneal space. Distal
arterial exposure varied according to the artery chosen for the
outﬂow anastomosis. An externally reinforced, 6-mm, thin-walled
PTFE graft was then tunneled between the proximal and distal
arterial dissections. The graft tunnel was routed medially when
possible; however, when a bypass graft to the proximal anterior
tibial artery was planned, the tunnel was made laterally. A lateral
tunnel was also used in cases where the distal peroneal artery was
targeted via a lateral approach with segmental ﬁbulectomy. Also
taken into consideration for graft tunneling was avoidance of
excessive scar formation or open wounds. After systemic heparin-
ization, the proximal anastomosis was performed using an end-to-side anastomosis between the PTFE graft and the inﬂow artery
with a standard “parachute” suturing technique. A DVP was per-
formed at the distal anastomosis of each bypass as previously
described.8 A 2e4 cm segment of autogenous tissue was harvested
including saphenous vein remnants, basilic vein, cephalic vein, and
rarely superﬁcial femoral vein. The tissue segment was gently
irrigated with prepared vein solution (Plasma-Lyte-A: 1000 mL, pH
7.4, heparin 5000 units, calcium chloride 10%, 100 mg, and
papaverine 120 mg) and opened longitudinally with any venous
valves directly excised. The distal arteriotomy was performed and
the vein segment sutured to the artery as a patch with 7-0 Prolene
by means of standard “parachute” techniques. A longitudinal
venotomy was then made in the proximal two thirds of the patch
in order to locate the prosthetic anastomosis near the heel of
artery-patch suture line but leaving the distal one third of the
venous anastomosis freeof anyPTFE. ThePTFEgraftwas then sutured
to the vein patch with 6-0 Prolene. (Fig. 1A) The vein patch provides
an autogenous interface between the artery and the prosthetic graft,
but does not “balloon out” in a hemodynamically disadvantageous
conﬁguration.11 (Fig. 1B) Completion arteriograms were obtained
routinely early in the series, but are currently obtained selectively
based on intraoperative ultrasound ﬁndings. (Fig. 2A and B).
The post operative protocol included the use of aspirin and
warfarin tomaximize graft function given that 6 mm ePTFE was the
conduit.12,13 Over 90% of patients were on aspirin preoperatively,
and the remaining were started on aspirin post bypass if they had
no contraindication to antiplatelet therapy. A heparin infusion was
started 2e4 h postoperatively to assure operative hemostasis and
continued for 48 h with conversion to oral warfarin therapy in
those patients without a contraindication to long-term anti-
coagulationwith an international normalized ratio between 1.8 and
Figure 2. Completion arteriograms after DVP bypass. A. Arteriogram after DVP bypass
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Figure 3. Graph of primary patency with corresponding life-table.
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Figure 4. Graph of limb salvage with corresponding life-table.
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discharge from the hospital. The follow-up protocol included
pulse examination and Duplex ultrasound surveillance at 3months,
6 months, and annually. If Duplex ultrasound revealed anastomotic
stenosis (increased velocities) or threatened ﬂow (decreased mid
graft velocity) then an arteriogram was performed to assess the
ability to extend graft function with an intervention. If a graft was
thrombosed at follow-up by Duplex ultrasound or pulse exam, the
patient was taken to the operating room for graft thrombectomy
and revision if feasible.
Results
Two hundred and seventy grafts were performed in two ﬁfty
four patients. The patient cohort was comprised of 54% males and
46% females with a mean age of 70.5  11.1 years. Racial demo-
graphics were 53.3% Caucasian, 43% Black, and 3.7% Hispanic and
Oriental. Comorbid conditions included diabetes mellitus (49.6%),
chronic renal failure on dialysis (20.6%), and medically treated
hypertension (68.2%). Indications for revascularization were clau-
dication (9.3%), rest pain (27.8%), gangrene (22.2%), and non-heal-
ing ulceration (40.7%) with 62.9% of patients presenting with tissue
loss. Prior revascularization had been attempted in 33.3%. Bypass
grafts originated from the external iliac artery in 29%, the common
femoral artery in 55%, the superﬁcial femoral artery in 13%, the
popliteal artery in 1%, and another graft limb in 2%. The recipient
arteries included the below knee popliteal in 6%, anterior tibial
artery in 25%, the posterior tibial artery in 30%, and the peroneal
artery in 39% procedures with tibial artery bypass comprising 94%
of the bypass cohort.
Graft patency and limb salvage rates were determined at follow-
up intervals ranging from 1 month to four years. There was one
(0.5%) perioperative death due to a myocardial infarction, with
a 12.6% total mortality rate during the four-year follow-up period.
Perioperative graft failure occurred within thirty days of surgery in
thirteen cases. There were an additional twenty eight failures
beyond this thirty day perioperative period for a total of 41 known
graft failures in the series. This led to 39 major amputations per-
formed above the ankle (BKA, AKA). Data were evaluated using
standard Kaplan Meyer life-table analysis and reported as primary
patency and limb salvage SE.5 Primary graft patency was
91.3%  2.0% at 6 months, 79.8%  3.4% at 12 months, 75.6%  4.4%
at 24 months, 65.9%  6.1%, at 36 months, and 51.2%  8.4% at 48
months. (Fig. 3) Limb salvage rates were 90.7%  2.1% at 6 months,
80.6% 3.4% at 12months, 78.0% 4.2% at 24months, 75.7% 5.6%
at 36 months, and 67.5%  8.0% at 48 months. (Fig. 4).Further analysis of the failed grafts included risk factor assess-
ment, as well as inﬂow and outﬂow graft anatomy. Twenty of the
graft failures (49%) occurred in diabetic patients who accounted for
57% of the patient series. Nine of the graft failures (22%) occurred in
the renal failure group which was 25% of the total series. This
indicated no disproportionate failure rates for diabetic or renal
failure patients. Inﬂowanatomy of the failed grafts showed that ﬁve
occluded grafts originated from the limb of a prior aorto-femoral
bypass graft representing 100% failure in this group.
Discussion
Several anastomotic modiﬁcations have been proposed to
improve prosthetic graft performance in patients requiring below
knee bypass. Our initial experience with the DVP technique
reported only 19 patients beyond two years of follow-up. A larger
patient cohort with longer follow-up intervals was deemed
necessary to conﬁrm the preliminary clinical ﬁndings. The current
study involves a larger patient cohort at extended periods of time
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follow-up interval. The primary patency rate at four years in this
expanded series is lower than reported in the initial study; 51% vs.
62%. The larger sample size at longer follow-up intervals reveals
a more accurate representation of DVP performance.
Venous tissue was ﬁrst interposed between the prosthetic graft
and a recipient artery in order to ease the technical difﬁculty of
suturing the stiff graft to small, calciﬁed arteries.14 Miller reported
on 114 infrainguinal procedures using a vein cuff technique with
a patency rate of 72% noted at 18 months.15 However, several
disadvantages were recognized with this conﬁguration including
signiﬁcant turbulence at the anastomotic reservoir and difﬁculty
achieving a proper angle between the graft and recipient artery.
These factors may explain the immediate and early graft failures
reported in Miller’s initial series. Taylor described a technique to
address several of these concerns reporting on 256 grafts (83 tibial
bypasses) with 1, 3, and 5-year patency rates of 74%, 58%, and 54%,
respectively.16 However, there are also disadvantages with this
technique. The tibial artery is directly exposed to PTFE graft
material for the proximal half of the anastomosis thereby losing the
advantage of venous endothelium for half the anastomosis. There
can also be a point of anastomotic constriction where the three
suture lines converge between the artery, PTFE, and vein patch.
Finally, a signiﬁcant length of vein must be available to accomplish
the anastomosis using the Taylor technique. The St Mary’s boot
technique has been advocated as taking advantage of the best
features of the prior techniques with promising early clinical
results. The corner of the vein is sutured to the apex of the arte-
riortomy to form the anastomotic toe. The remainder of the
venous-arterial anastomosis is formed in a similar fashion to the
Miller cuff, however the redundant vein is excised obliquely and
sutured to the longitudinal edge. A segment of the posterior collar
is incised to increase the size of the anastomosis between the graft
and vein collar. The St Mary’s boot maintains a fully compliant
venous collar, avoids any direct contact between artery and PTFE,
andmaintains the hemodynamic advantages of the Taylor patch. Its
main drawback is the increased suturing technical complexity.17
Technique is critical for the successful construction of the MillerTable 1
Comparative table including data gleaned from articles that reported results on speciﬁc da
may have been collected in the context of a trial involving other techniques, and only dat
were used. While not a statistical comparison, this is as near a comparison of like-kind d
Series N BK popliteal vs Tibial
Miller Cuff
Miller, 198415 114
Raptis, 199527 BK popliteal 100%
Stonebridge, 199719 96 BK popliteal 100%
Kansal, 199918 56 BK popliteal 47% Tibial 53%
Stonebridge, 200028 89 Tibial 100%
Panneton, 200429 44 BK popliteal 21% Tibial 79%
Grifﬁths, 200430 BK popliteal 100%
Oderich, 200531 BK popliteal 35% Tibial 65%
Lauterbach, 200532 105 BK popliteal 38% Tibial 62%
Taylor Patch





Kreienberg, 200020 59 BK popliteal 12% Tibial 88%
Kreienberg, 200221 20 BK popliteal 20% Tibial 80%
DVP
Neville, 200110 80 Tibial 100%
Flis, 200122 86 BK popliteal Tibial
Bellosta, 200523 22 Tibial 100%
Neville, 2012 (current) 270 BK popliteal 6% Tibial 94%cuff, Taylor patch, and St. Mary’s boot. The DVP technique was
developed in response to this apparent complexity and theoretical
disadvantages. We combined a standard patch angioplasty tech-
nique familiar to vascular surgeons with subsequent implantation
of the PTFE graft into the patch.
Several authors have reported their results with these tech-
niques. (Table 1) Kansal and colleagues obtained improved patency
for prosthetic bypasses with the Miller cuff when as compared to
historical controls with straight PTFE.18 A prospective, randomized
trial utilizing PTFE grafts with and without a Miller vein cuff was
reported by Stonebridge. This series did not demonstrate a statis-
tically signiﬁcant beneﬁt for the vein cuff technique in tibial
bypasses, although there was a trend toward improved patency at
24 months.19 Kreienberg compared grafts using PTFE with a vein
cuff versus composite saphenous vein grafts. Primary patency was
similar at two years; 49% cuff vs. 44% composite vein with
secondary patency rates somewhat better for the composite vein
group.20 The Albany group compared all bypasses with spliced vein
segments to PTFE and a Miller vein cuff.21 The patency was better
with the vein bypasses although 25% of the spliced vein procedures
required revision to obtain these results. Additionally, spliced vein
procedures involved increased operative time, hospital stay, intra-
operative blood loss, and perioperative morbidity. Therefore,
composite grafts of poor quality vein do not function any better
than PTFE with a vein cuff or patch and generate a higher rate of
morbidity and use of hospital resources. Our results have been
supported by European studies using the same technique. Flis
found improved primary patency and limb salvage using the DVP
bypass as compared to PTFE alone.22 Bellosta compared the DVP,
the vein cuff, and pre-cuffed PTFE and demonstrated that the DVP
provided better results than the other two distal anastomotic
conﬁgurations.23
The reasons for suboptimal performance with prosthetic grafts
especially below the knee are technical, biological, and hemody-
namic. Technically, the anastomosis involves suturing a prosthetic
graft material to small, often calciﬁed tibial arteries. Biologically,
PTFE grafts are more thrombogenic than autogenous conduits with
increased platelet adhesion and activation of the coagulationta points with theMiller cuff, Taylor patch, St. Mary’s boot, and Distal Vein Patch. Data
a that could be gleaned from the publication regarding vein interposition techniques
ata as possible.
















82 77 69 62
53 vs 29
62 (secondary)
79 75 65 51
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early graft thrombosis especially when blood ﬂow falls below the
critical thrombotic threshold. Late graft failure due to myointimal
hyperplasia occurs six to twenty four months postoperatively
usually at the distal anastomosis. This hyperplastic response is the
result of smooth muscle cell migration and proliferation primarily
at the toe and heel of the anastomosis causing a reduction in lumen
area and subsequent graft failure. Although the causes of myoin-
timal hyperplasia have not been completely delineated, viable
venous tissue at the anastomosis may create a “biologic buffer
zone” and alter the stimulation of factors responsible for the
hyperplasia responsible for late failure with PTFE.25 Venous endo-
theliummay also confer a beneﬁcial effect through antiplatelet and
ﬁbrinolytic activity, although these effects remain unproven. The
hemodynamic factors of shear stress and compliance mismatch
have also been implicated in prosthetic graft failure. Hypothetically,
vein interposed between the prosthetic material and the more
compliant artery would minimize the expansibility mismatch
created with pulsatile ﬂow and thus decrease mechanical injury at
the anastomosis. However, an animal study addressing compliance
did not prove compliance to be a signiﬁcant contributory factor in
the reduction of hyperplasia.26 Anastomotic turbulence, shear
forces and outﬂow resistance have also been suggested as mecha-
nisms of graft failure. Anastomotic geometry may be altered by the
presence of vein at the distal anastomosis, thereby effecting
turbulence and shear forces that play a role in the hyperplastic
process. We have used magnetic resonance velocimetry with three
dimensional, time varying velocity measurements to analyze
hemodynamics in differing anastomotic geometries.11 Flow struc-
tures revealed marked hemodynamic differences between stan-
dard and cuffed anastomotic geometries. The ﬁndings supported an
end-to-side anastomosis with a low incident angle as producing
a favorable hemodynamic result as compared to a Miller pre-cuffed
conﬁguration. The DVP and Taylor anastomoses closely approxi-
mate the hemodynamic advantages of the conventional, straight
anastomotic pattern. Finally, venous tissue may simply enlarge the
distal anastomosis so that the formation of hyperplasia must
encroach on a wider lumen to cause its occlusion making this
response less critical when a patch is added to the distal
anastomosis.
We developed the DVP to incorporate techniques familiar to
vascular surgeons while maintaining the proposed advantages of
vein interposition in improving outcomes for prosthetic grafts. The
DVP involves a standard patch angioplasty technique familiar to
vascular surgeons with implantation of a PTFE graft into the
proximal portion of the vein patch. The length of autogenous tissue
required for the patch is minimized compared to theMiller cuff and
Taylor patch. Autogenous tissue is interposed between the graft and
the recipient arterial wall for the entire anastomosis unlike the
Taylor patch, and there is not the “bulging” noted with the Miller
cuff. Diabetes and renal failure did not have a disproportionate
incidence of graft failure, and remain candidates for DVP bypass if
needed for limb salvage. The patency rate in the current series
represents a more mature evaluation of the DVP technique with
more robust long-term follow-up as compared to series reporting
other vein interposition techniques.
There was an important observation from grafts that did fail.
Graft thrombectomy and revision was simpliﬁed by this technique.
Ordinarily, prosthetic grafts fail due to hyperplasia at the suture line
between the graft and recipient artery resulting in thrombosis of
the recipient artery. When the DVP bypasses failed, the recipient
artery was rarely thrombosed because the hyperplastic response
led to stenosis between the vein patch and ePTFE, leaving the native
artery patent and available for revision. This allowed reestablish-
ment of graft patency by thrombectomy with revision of the distalanastomosis by extension of the patch across the hyperplastic area
onto patent native artery.
In this era of endovascular therapy, lower extremity bypass
will become increasingly challenging as catheter based therapies
continue to evolve. Patients with extensive occlusive disease and
signiﬁcant tissue loss may be best treated with bypass. Accord-
ingly, bypass will be used in this cohort for non-healing wounds
or gangrene especially when direct, pulsatile perfusion is required
for healing and maximal tissue salvage. This aggressive approach
to limb salvage and wound healing will require bypass in patients
without an adequate length of autogenous conduit. Our initial
experience with the DVP was encouraging, but limited in terms of
long-term follow-up. We believe the DVP anastomosis involves
technical, biological, and hemodynamic factors that lead to the
reported results. As compared to our initial report, this expanded
series is an enhanced reﬂection of expected performance with
the DVP bypass, and conﬁrms that PTFE with a DVP leads to
acceptable long-term patency and limb salvage in patients with
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